An Uncommon Case of Myocarditis Secondary to Durvalumab Plus Tremelimumab

Tumor immunotherapy is an important clinical strategy for the treatment of various solid and hematological malignancies, and its use is on the rise. Immune checkpoint inhibitors (ICIs) are immunotherapies that boost anticancer immune responses by targeting receptors on the surface of T-lymphocytes....

Descripción completa

Detalles Bibliográficos
Autores principales: Diaz-Rodriguez, Porfirio E, Muns-Aponte, Claudia M, Velazquez-Acevedo, Sharolyn I, Ortiz-Malave, Cristina M, Acevedo, Jose, Merced-Ortiz, Francisco G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504866/
https://www.ncbi.nlm.nih.gov/pubmed/37719633
http://dx.doi.org/10.7759/cureus.43628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504866/
https://www.ncbi.nlm.nih.gov/pubmed/37719633
http://dx.doi.org/10.7759/cureus.43628

Ejemplares similares